T84.020D vs T84.021D
T84.020D (Dislocation of internal right hip prosthesis, subsequent encounter) compared with T84.021D (Dislocation of internal left hip prosthesis, subsequent encounter), from the official CMS tabular data. T84.020D and T84.021D code the same condition on opposite sides.
Can these codes be reported together?
Same condition, opposite side. T84.020D and T84.021D name the same condition on opposite sides of the body.
Same category and title, differing only in which side is affected — the documentation decides which one applies, and a bilateral code is reported only where the code set provides one.
Side by side
| T84.020DDislocation of internal right hip prosthesis, subsequent encounter | T84.021DDislocation of internal left hip prosthesis, subsequent encounter | |
|---|---|---|
| Billing status | Billable | Billable |
| Classification | S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) | S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) |
| Definition | Dislocation of internal right hip prosthesis, subsequent encounter is a billable ICD-10-CM diagnosis code (T84.020D). | Dislocation of internal left hip prosthesis, subsequent encounter is a billable ICD-10-CM diagnosis code (T84.021D). |
| 7th character | The appropriate 7th character is to be added to each code from category T84 | The appropriate 7th character is to be added to each code from category T84 |
| Use additional code | code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) code(s) to identify the specified condition resulting from the complication code to identify devices involved and details of circumstances (Y62-Y82) | code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) code(s) to identify the specified condition resulting from the complication code to identify devices involved and details of circumstances (Y62-Y82) |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources